Latest News - Atopic Dermatitis

Monday, February 13, 2017 | PracticalDermatology.com, Research and Publications

Intramuscular Flu Shots May Mitigate Staph Risk In AD Patients

Staphylococcus colonization of atopic dermatitis patients’ skin is associated with a weaker response to intradermal flu shots, according to a new study which suggests that intramuscular flu…

Read the full story

Friday, February 10, 2017 | PracticalDermatology.com, Research and Publications

Cochrane Review: All Moisturizers Created Equally for Eczema

No one moisturizer is better than another when it comes to relieving the symptoms of eczema, according to a new Cochrane Review. Overall, most moisturizers show beneficial effects for eczema, work …

Read the full story

Monday, February 06, 2017 | PracticalDermatology.com, Product Launches and Updates, Atopic Dermatitis , Eczema, PuraCap

PuraCap: Video Available to Educate Families, Children

A new video from PuraCap® Pharmaceutical explores the effects of childhood eczema and how parents and kids can find relief. As many as one out of every three kids suffe…

Read the full story

Monday, January 30, 2017 | PracticalDermatology.com

Realm Therapeutics Submits Investigational New Drug Application for PR022 for Atopic Dermatitis

Realm Therapeutics plc submitted its first investigational new drug (IND) application to the FDA for PR022 as a novel treatment for atopic dermatitis (AD).  Pending acceptance, the IND will enabl…

Read the full story

Thursday, January 26, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications, Melanoma

Congratulations: American Skin Association Announces 2017 Research Scholar Awards and Research Grants

And the winners are … The American Skin Association (ASA) research scholar awards and research grants are: ASA Carson Research Scholar Award in Psoriasis Cory L. Simpson, MD, PhD Un…

Read the full story

Tuesday, January 17, 2017 | PracticalDermatology.com, Product Launches and Updates, Atopic Derm, Atopic Dermatitis

Encore Dermatology Inc. Launches TridesilonTM (desonide) Cream, 0.05% for AD

Encore Dermatology Inc. is rolling out TridesilonTM (desonide) Cream, 0.05% in a 60g tube for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. …

Read the full story

Friday, January 06, 2017 | PracticalDermatology.com, Research and Publications

Menlo Begins Enrollment for Phase 2 Studies of NK-1 for Pruritus

Menlo Therapeutics Inc. has initiated enrollment in two new Phase 2 trials evaluating a novel neurokinin 1 (NK-1) receptor antagonist, serlopitant, for the treatment of pruritus associated with atopic…

Read the full story

Wednesday, January 04, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Study Examines Diversity in Dermatologic Clinical Trials

Dermatologic clinical trials within the United States reflect the growing diversity of the US population, but reporting of both sex and racial/ethnic diversity of research cohorts is still lacking, es…

Read the full story

Wednesday, December 21, 2016 | Acquisitions and Mergers, PracticalDermatology.com, Product Launches and Updates

Dermavant Licenses Portola Pharma’s Cerdulatinib For Skin Applications

Dermavant Sciences has licensed cerdulatinib from Portola Pharma for topical dermatologic applications. Cerdulatinib is a dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor tha…

Read the full story

Wednesday, December 14, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Anacor, Pfizer

FDA Approved Eucrisa (Crisaborole) for AD

The U.S. Food and Drug Administration approved Eucrisa (crisaborole) ointment to treat mild-to-moderate eczema in patients two years of age and older.  Eucrisa, applied topically twice daily, …

Read the full story

Tuesday, December 13, 2016 | FDA Approval/Clearance, PracticalDermatology.com

AnaptysBio, Inc.’s IL-33-Blocker Cleared for Phase 2a Trials in AD, Peanut Allergy

The United Kingdom Medicines and Healthcare Products Regulatory Agency has green lighted a Phase 2a clinical trial for AnaptysBio, Inc.’s ANB020 for the treatment of adults with moderate-to-seve…

Read the full story

Tuesday, December 06, 2016 | PracticalDermatology.com, Research and Publications

Can Vaseline Protect High-Risk Infants from Eczema? Study Says Yes

Applying low-cost moisturizers including petroleum jelly to a baby's skin for the first six months of his or her life is a cost-effective way to prevent eczema, finds a new study published in JAMA…

Read the full story

Monday, November 28, 2016 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Study: Anxiety Linked to Skin Disease

Anxiety disorders tend to be followed by skin diseases, according to psychologists at the University of Basel in Switzerland and Ruhr University Bochum in Germany. The study, which appears in the j…

Read the full story

Friday, November 18, 2016 | PracticalDermatology.com, Research and Publications

Food Allergy Linked to Early Exposure Through Broken Skin

Early exposure to a food allergen through broken skin might prompt the development of food allergy, according to new research in Allergy and Asthma Proceedings. This theory gained further support f…

Read the full story

Thursday, November 03, 2016 | PracticalDermatology.com, Research and Publications, Santalis Pharmaceuticals

FDA OKS Santalis’ Phase 2 Study of EISO For AD

The U.S. Food and Drug Administration (FDA) has green lighted Santalis Pharmaceuticals Phase 2 clinical study of East Indian Sandalwood Oil (EISO) cream for the treatment of atopic dermatitis (AD). …

Read the full story
Load More